vancomycin oral
Selected indexed studies
- Does oral vancomycin use necessitate therapeutic drug monitoring? (Infection, 2020) [PMID:31713055]
- Oral Vancomycin for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial. (JAMA Netw Open, 2025) [PMID:40601321]
- Oral Vancomycin for Secondary Prophylaxis of Clostridium difficile Infection. (Ann Pharmacother, 2019) [PMID:30450942]
_Worker-drafted node — pending editorial review._
Connections
vancomycin oral is a side effect of
Sources
- Does oral vancomycin use necessitate therapeutic drug monitoring? (2020) pubmed
- Oral Vancomycin for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial. (2025) pubmed
- Oral Vancomycin for Secondary Prophylaxis of Clostridium difficile Infection. (2019) pubmed
- Efficacy of Oral Vancomycin in Preventing Recurrent Clostridium difficile Infection in Patients Treated With Systemic Antimicrobial Agents. (2016) pubmed
- Oral vancomycin induced flushing syndrome in a multiple myeloma patient: A case report and review of the literature. (2024) pubmed
- Oral vancomycin use and incidence of vancomycin-resistant enterococci: time-series analysis. (2024) pubmed
- Oral vancomycin for primary sclerosing cholangitis and associated inflammatory bowel disease - paving a path forward. (2026) pubmed
- Vancomycin Flushing Syndrome Following Oral Administration of Vancomycin. (2023) pubmed
- Oral Delivery of the Vancomycin Derivative FU002 by a Surface-Modified Liposomal Nanocarrier. (2024) pubmed
- Oral vancomycin for Clostridioides difficile prophylaxis in allogenic hematopoietic cell transplant. (2022) pubmed